Fig. 4From: Long-term survival achieved by repeated administration of ramucirumab after drug holidays due to proteinuria in recurrent gastric cancera Recurrent No. 16b1 enlarged to 20.1 mm after SOX therapy. b Lesion shrank to 15.6 mm after three courses of RAM + PTX therapy. c Lesion enlarged to 18.1 mm during the first RAM withdrawal period. d Lesion again shrank to 10.5 mm with resuming RAM administration.Back to article page